Published on: 25 January 2021 Roche renews partnership with Sysmex to deliver haematology testing solutions more
Published on: 25 January 2021 Roche’s faricimab meets primary endpoint in two global phase III studies and shows potential to extend time between treatments up to 16 weeks for people with neovascular age-related macular degeneration more
